Antineoplastic drug occupational exposure: a new integrated approach to evaluate exposure and early genotoxic and cytotoxic effects by no-invasive Buccal Micronucleus Cytome Assay biomarker.

[1]  N. Rezaei,et al.  Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of oncology department personnel handling anti-neoplastic drugs , 2017, Drug and chemical toxicology.

[2]  E. Ceretti,et al.  Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach , 2015, International Archives of Occupational and Environmental Health.

[3]  M. McDiarmid,et al.  Reproductive Health Risks Associated With Occupational Exposures to Antineoplastic Drugs in Health Care Settings: A Review of the Evidence , 2014, Journal of occupational and environmental medicine.

[4]  S. Viegas,et al.  Assessment of Genotoxic Effects in Nurses Handling Cytostatic Drugs , 2014, Journal of toxicology and environmental health. Part A.

[5]  E. Ceretti,et al.  Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: assessment of DNA damage , 2013, Occupational and Environmental Medicine.

[6]  Anna N. Vioral,et al.  Implementation of the American Society of Clinical Oncology and Oncology Nursing Society chemotherapy safety standards. , 2012, Clinical journal of oncology nursing.

[7]  M. Fenech,et al.  The HUman MicroNucleus project on eXfoLiated buccal cells (HUMN(XL)): the role of life-style, host factors, occupational exposures, health status, and assay protocol. , 2011, Mutation research.

[8]  G. Tranfo,et al.  Molecular biomonitoring of a population of nurses handling antineoplastic drugs. , 2008, Mutation research.

[9]  M. Chandrasekhar,et al.  Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs. , 2007, Mutagenesis.

[10]  S. Iavicoli,et al.  Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs , 2006, International archives of occupational and environmental health.

[11]  S. Fustinoni,et al.  Assay of urinary alpha-fluoro-beta-alanine by gas chromatography-mass spectrometry for the biological monitoring of occupational exposure to 5-fluorouracil in oncology nurses and pharmacy technicians. , 2006, Biomedical chromatography : BMC.

[12]  Sergio Iavicoli,et al.  Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. , 2005, Mutation research.

[13]  A. Pietropaolo,et al.  Measurement of surface contamination by certain antineoplastic drugs using high-performance liquid chromatography: applications in occupational hygiene investigations in hospital environments. , 1999, La Medicina del lavoro.

[14]  A. Pietropaolo,et al.  Measurement of surface contamination from nucleoside analogue antineoplastic drugs by high-performance liquid chromatography in occupational hygiene studies of oncologic hospital departments. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[15]  R. Anzion,et al.  Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics. , 1999, Mutation research.

[16]  R. Jacob,et al.  Micronuclei in lymphocytes and exfoliated buccal cells of postmenopausal women with dietary changes in folate. , 1997, Mutation research.

[17]  G. Machado-Santelli,et al.  Biomonitoring of nurses handling antineoplastic drugs. , 1994, Mutation research.

[18]  M. Ro̸rth,et al.  Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. , 1992, British journal of industrial medicine.

[19]  K. Straif,et al.  A review of human carcinogens--Part A: pharmaceuticals. , 2009, The Lancet. Oncology.